- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05165511
Families, Responsibility, Education, Support, and Health for Executive Function (FRESH-EF)
March 2, 2026 updated by: Dawn Eichen, University of California, San Diego
Executive Function Enhanced Parent-Based Treatment for Children With ADHD and Overweight or Obesity
The pilot study will be a one group open-label treatment program and will be used to refine a parent-based behavioral treatment enhanced with executive-function training (PBT-EF) for children with comorbid overweight or obesity and Attention-Deficit Hyperactivity Disorder (ADHD).
Study Overview
Status
Withdrawn
Intervention / Treatment
Detailed Description
The currently recommended treatment for children with overweight or obesity (OW/OB), family-based behavioral treatment (FBT), results in sustained weight loss for only 1/3 of children.
Attention-Deficit Hyperactivity Disorder (ADHD) is one of the most common neurobehavioral disorders in children and is characterized by difficulties in Executive Function (EF).
Substantial research suggests higher rates of OW/OB in children with ADHD; thus, children with OW/OB and ADHD are likely to have greater difficulties with EF and achieving success in FBT.
The proposed study aims to develop a parent-based behavioral treatment enhanced with EF training (PBT-EF) to improve treatment outcomes for children with comorbid OW/OB and ADHD.
The treatment will be administered to parents in 18 group sessions over 5 months.
Parents and children will be assessed at baseline, post-treatment, and 3-month follow-up.
Assessments will include body mass index (BMI), assessments of executive function, and behavioral questionnaires.
This study could provide a novel model to treat OW/OB in children with ADHD, and could inform clinical decision making regarding obesity treatment.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92037
- UCSD Center for Healthy Eating and Activity Research (CHEAR)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 12 years (Child)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Child with overweight or obesity (85-99.9% BMI for age),
- Child age 8-12,
- Child with a diagnosis of ADHD,
- A parent willing to participate who can read and understand English at a minimum of a fifth-grade level, able to attend treatment sessions remotely via Zoom on video.
Exclusion Criteria:
- Current enrollment in an organized weight control program (parent and child)
- Medication specifically prescribed for weight loss (child)
- Medical or psychiatric condition that may interfere with treatment participation or that may require physician monitoring of diet and/or exercise (e.g., acute suicidality; psychosis; substance use disorder) (parent and child)
- Change in psychotropic medication or other medication that may impact weight or ADHD symptoms during the previous 3 months (child)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Executive Function-Enhanced Parent-Based Behavioral Treatment (PBT-EF)
PBT-EF will integrate executive function training with family-based behavioral treatment (FBT) for obesity, the gold-standard behavioral treatment for childhood obesity.
PBT-EF will include self-monitoring, calorie reduction, and dietary and physical activity recommendations in addition to planning, organization, and problem-solving skills.
|
PBT-EF will be delivered to parents only.
Parents will be taught general behavioral weight loss skills to apply to their child and themselves including decreasing caloric intake and increasing physical activity, self-monitoring, and goal setting.
Additionally, parents will learn compensatory strategies surrounding organization, habit learning, planning, and problem-solving to generalize FBT skills to real-world behaviors (e.g., self-monitoring of food intake).
Each session will include interactive exercises to help train an aspect of EF.
Skills taught will be presented to be practiced with real-world applications.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility as measured by number of treatment sessions attended
Time Frame: Over the course of 5 months of treatment
|
Attendance at Treatment Sessions
|
Over the course of 5 months of treatment
|
|
Acceptability
Time Frame: At 5 months
|
Ratings of usefulness of treatment
|
At 5 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child body mass index (BMI)
Time Frame: Change from baseline at an average of 5 months and 8 months
|
As measured by height and weight (kg/m^2)
|
Change from baseline at an average of 5 months and 8 months
|
|
Child executive function
Time Frame: Change from baseline at an average of 5 months and 8 months
|
Change in executive function measured by Behavior Rating in Executive Functioning - 2 (BRIEF-2).
The Global Executive Composite score reflects a standardized t-score with higher scores reflecting greater difficulties in executive function.
|
Change from baseline at an average of 5 months and 8 months
|
|
Parent executive function
Time Frame: Change from baseline at an average of 5 months and 8 months
|
Change in executive function measured by Behavior Rating in Executive Functioning - Adult (BRIEF-A).
The Global Executive Composite score reflects a standardized t-score with higher scores reflecting greater difficulties in executive function.
|
Change from baseline at an average of 5 months and 8 months
|
|
Child behavioral symptoms - Child Behavior Checklist (CBCL)
Time Frame: Change from baseline at an average of 5 months and 8 months
|
Change in child behavioral symptoms rated by parents as measured by CBCL.
The CBCL is a widely used parent-report questionnaire designed to assess behavioral problems and social competencies of children ages 4-18.
It yields standardized T scores and age adjusted scores on internalizing, externalizing, and total behavior difficulties.
Higher scores reflect greater behavioral difficulties.
|
Change from baseline at an average of 5 months and 8 months
|
|
Child behavioral symptoms - Vanderbilt ADHD [Attention Deficit Hyperactivity Disorder] Parent Rating Scale
Time Frame: Change from baseline at an average of 5 months and 8 months
|
Change in child behavioral symptoms rated by parents as measured by Vanderbilt ADHD Parent Rating Scale.
This scale is a parent-report questionnaire.
The parent rates the frequency of 47 behaviors that may indicate behavioral issues.
There are also 8 performance questions.
Change in total symptoms of the 18 ADHD criteria will be reported.
Higher scores reflect greater ADHD symptomatology.
|
Change from baseline at an average of 5 months and 8 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Dawn M Eichen, PhD, University of California, San Diego
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 26, 2022
Primary Completion (Actual)
May 1, 2025
Study Completion (Actual)
May 1, 2025
Study Registration Dates
First Submitted
December 7, 2021
First Submitted That Met QC Criteria
December 7, 2021
First Posted (Actual)
December 21, 2021
Study Record Updates
Last Update Posted (Actual)
March 4, 2026
Last Update Submitted That Met QC Criteria
March 2, 2026
Last Verified
March 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Mental Disorders
- Nutrition Disorders
- Overnutrition
- Body Weight
- Body Weight Changes
- Neurodevelopmental Disorders
- Attention Deficit and Disruptive Behavior Disorders
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Overweight
- Obesity
- Weight Loss
- Attention Deficit Disorder with Hyperactivity
Other Study ID Numbers
- 210123
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
PfizerNot yet recruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on PBT-EF
-
Vita CareTegos S.A.CompletedOsteoarthritis | Osteoarthritis Hand | Osteoarthritis Finger | Osteoarthritis Both HandsBrazil
-
Royal Holloway UniversityGreat Ormond Street Hospital for Children NHS Foundation Trust; The Hillingdon... and other collaboratorsCompletedPrimary Headaches (Includes Migraines, Tension, Cluster Headaches)United Kingdom
-
Everfront Biotech Co., Ltd.Not yet recruitingPancreatic Cancer
-
S.LAB (SOLOWAYS)Center for New Medical Technologies, Novosibirsk, Russia; Activator MAF, LLCCompletedRheumatoid ArthritisRussia
-
University of Alabama at BirminghamNot yet recruiting
-
Samsung Medical CenterCompletedSide Effect | Local Control RateKorea, Republic of
-
University Hospital, MontpellierActive, not recruitingIschemic Stroke | Migraine | Migraine With AuraFrance
-
Concordia University, MontrealCanadian Institutes of Health Research (CIHR)CompletedAging | Age Related Hearing LossCanada
-
The University of Tennessee, KnoxvilleCompleted